September 22, 2021 Bayer to launch organic vegetable seeds portfolio enabling greater access to certified organic marketRead more
SPECIALIZED PRESS September 20, 2021 Not intended for U.S. and UK MediaBayer extends clinical development program for finerenone with Phase III study in patients with non-diabetic chronic kidney diseaseRead more
September 16, 2021 Launch of Bayer Science Collaboration Explorer:Bayer launches transparency register for scientific collaborations with external partnersRead more
SPECIALIZED PRESS September 16, 2021 Not intended for U.S. and UK Media – ESMO Congress 2021:Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy and tolerability profile for both adult and pediatric patients with TRK fusion cancerRead more
September 14, 2021 Andes raises USD 15 million in Series A funding co-led by Leaps by Bayer and Cavallo VenturesRead more
September 9, 2021 SVG Ventures | THRIVE and Bayer Announce their Sustainability Challenge WinnersRead more
SPECIALIZED PRESS September 9, 2021 Not intended for U.S. and UK MediaBayer to highlight expanded research from growing oncology portfolio at ESMO Congress 2021Read more
SPECIALIZED PRESS September 6, 2021 Not intended for U.S. and UK MediaBayer’s Eliapixant significantly decreased cough frequency in Phase IIb trial in patients with refractory chronic coughRead more
SPECIALIZED PRESS August 31, 2021 Not intended for U.S. and UK MediaBayer starts Phase III clinical development program OASIS with ElinzanetantRead more
